Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2026-04-04 @ 11:22 AM
Study NCT ID:
NCT00268203
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2005-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma, Non-Hodgkin | View |